Psychopharmacology is an international journal discussing the mechanisms by which drugs influence behavior.
This is a transformative journal, you may have access to funding.
Cannabinoids regulate the HPA-axis allowing an individual to regulate a healthy level of stress. But there is also evidence to suggest that the levels of circulating endocannabinoids such as AEA and 2-AG are different between individuals and are impacted by genetics and environment. We are interested in papers from animal and human studies including original articles and reviews.
Deadline: Initial submissions due September 1st, 2024.
We are pleased to announce an upcoming Special Issue of Psychopharmacology on Innovating translational models of affective disorders.
Initial submissions will be due October 1, 2022, with a likely publication date by early 2023.
We are pleased to announce an upcoming Special Issue of Psychopharmacology on Social Behaviors based on the 2022 EBPS Workshop.